Evidence map›Paper›PMID 35612809›Full record

SynthesisAdvances in experimental medicine and biology2022

Periodontal Cell Therapy: A Systematic Review and Meta-analysis.

Antoine Dubuc, Valérie Planat-Bénard, Mathieu Marty, Paul Monsarrat, Philippe Kémoun

Abstract readMeta-AnalysisSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Advances in experimental medicine and biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
22.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Antoine DubucDental Faculty, Paul Sabatier University, Toulouse Hospital (Hôpitaux de Toulouse) University, and Toulouse Institute of Oral Medicine, Toulouse, France.
Valérie Planat-BénardRESTORE Research Center, Université de Toulouse, INSERM 1301, CNRS 5070, EFS, ENVT, Toulouse, France.
Mathieu MartyDental Faculty, Paul Sabatier University, Toulouse Hospital (Hôpitaux de Toulouse) University, and Toulouse Institute of Oral Medicine, Toulouse, France.
Paul MonsarratDental Faculty, Paul Sabatier University, Toulouse Hospital (Hôpitaux de Toulouse) University, and Toulouse Institute of Oral Medicine, Toulouse, France.
Philippe KémounDental Faculty, Paul Sabatier University, Toulouse Hospital (Hôpitaux de Toulouse) University, and Toulouse Institute of Oral Medicine, Toulouse, France. philippe.kemoun@univ-tlse3.fr.
Université Fédérale de Toulouse Midi-Pyrénées · FRUniversité Toulouse III - Paul Sabatier · FRÉcole Nationale Vétérinaire de Toulouse · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPeriodontitis is a chronic inflammatory disease characterized by the loss of tooth-supporting tissues (or periodontium) leading to the formation of periodontal pocket then to tooth loss. Conventional therapies that involve tooth root debridement are still disappointing because they are more centered on periodontal repair than disease pathophysiology causes. The meta-analysis we present here focused on the results of experimental studies that investigated periodontal mesenchymal stromal cells (MSCs) therapy, a promising strategy to regenerate tissue, given to their immunomodulatory and trophic properties.

methodsUsing PubMed database and ICTRP search portal, 84 animal and 3 randomized human studies were analyzed.

resultsOverall, our results highlighted that MSCs grafting, regardless of their tissue origin, enhances periodontal regeneration. A defect morphology suitable for an initial clot stabilization increases the procedure efficacy, especially if cells are carried using a vehicle from natural origin. Nevertheless, methodological biases have been highlighted and still limit the translation to human with high prognosis and regulatory considerations. Besides, because only 2 randomized human trials demonstrated the efficacy of the procedure, further studies are needed to investigate periodontal regeneration procedures on experimental models closer to human pathophysiology.

conclusionAlthough MSCs grafting in periodontal disease demonstrated therapeutic benefits in animal, it is critical to define more accurately protocols translatable to human and focus on the treatment of the pathology as a whole rather than on the restitution of the sole destroyed tissues.

Indexed as

Mesenchymal Stem CellsPeriodontitisAnimalsCell- and Tissue-Based TherapyGuided Tissue Regeneration, PeriodontalPeriodontal LigamentPeriodontiumCell carrierCell therapyMesenchymal stromal cellMeta-analysisPeriodontal diseasePeriodontitisTissue engineering

Identifiers

PMID35612809
OpenAlexW4285239474

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.